#gism

LIVE
1.2k

Anya Rossi

sweetdream.ai

SweetDream.aiSponsored•Livecam
Streaming Now

Watch Anya Live

Anya is streaming live right now! Join her private show and enjoy exclusive content.

HD live stream
Exclusive private shows
1.2k viewers online

Free preview available • Premium content

GI Cancer Highlights from #ASCO25 w/ Dr. Cathy Eng ✅ #DYNAMIC3 ✅ #ATOMIC ✅ #BREAKWATER ✅ #MATTERHORN ✅ #DESTINYGastric04 Full Discussion: - - Also on the “Oncology Brothers” podcast #gism ASCO #OncTwitter #MedTwitter
1:43
OncBrothers's profile picture

GI Cancer Highlights from #ASCO25 w/ Dr. Cathy Eng ✅ #DYNAMIC3 ✅ #ATOMIC ✅ #BREAKWATER ✅ #MATTERHORN ✅ #DESTINYGastric04 Full Discussion: - - Also on the “Oncology Brothers” podcast #gism ASCO #OncTwitter #MedTwitter

Oncology Brothers

61,635 views • 1 year ago

Treatment Algorithm series: Discussion w/ Emil Lou, MD, PhD, FACP on #PancreaticCancer ✅ NeoAdj/Adj Chemo ✅ Metastatic Panc ✅ PARPi Full 🔊: ⭐️ ⭐️ ⭐️ “Oncology Brothers” podcast #gism #OncTwitter CancerNetwork®
1:10
OncBrothers's profile picture

Treatment Algorithm series: Discussion w/ Emil Lou, MD, PhD, FACP on #PancreaticCancer ✅ NeoAdj/Adj Chemo ✅ Metastatic Panc ✅ PARPi Full 🔊: ⭐️ ⭐️ ⭐️ “Oncology Brothers” podcast #gism #OncTwitter CancerNetwork®

Oncology Brothers

41,671 views • 1 year ago

Treatment Algorithm series: Discussion w/ Tim Brown, MD MSCE on GEJ/Gastric Adeno ✅ ESOPEC ✅ Adj Nivo ✅ Biomarkers: MSI, PDL1, HER2, CLDN18.2 Full 🔊: ⭐️ ⭐️ ⭐️ “Oncology Brothers” podcast #gism #OncTwitter CancerNetwork®
1:10
OncBrothers's profile picture

Treatment Algorithm series: Discussion w/ Tim Brown, MD MSCE on GEJ/Gastric Adeno ✅ ESOPEC ✅ Adj Nivo ✅ Biomarkers: MSI, PDL1, HER2, CLDN18.2 Full 🔊: ⭐️ ⭐️ ⭐️ “Oncology Brothers” podcast #gism #OncTwitter CancerNetwork®

Oncology Brothers

38,158 views • 1 year ago

GI Malignancies Highlights from #ESMO25 with Rachna Shroff, MD, MS, FASCO! ✅ #DYNAMICIII & #PEGASUS ✅ #STELLAR303 ✅ #MATTERHORN ✅ #FORTITUDE101 Full Discussion: - - Also on “Oncology Brothers” podcast #OncTwitter #gism ESMO - Eur. Oncology OncUpdates
1:09
OncBrothers's profile picture

GI Malignancies Highlights from #ESMO25 with Rachna Shroff, MD, MS, FASCO! ✅ #DYNAMICIII & #PEGASUS ✅ #STELLAR303 ✅ #MATTERHORN ✅ #FORTITUDE101 Full Discussion: - - Also on “Oncology Brothers” podcast #OncTwitter #gism ESMO - Eur. Oncology OncUpdates

Oncology Brothers

19,203 views • 7 months ago

#GISeries: #Zolbetuximab was approved based off #GLOW & #SPOTLIGHT! We discussed the design, findings, sequencing and AEs/management w/ Kohei shitara Full Discussion: ⭐️ ⭐️ Also on the “Oncology Brothers” podcast #OncTwitter #MedTwitter #gism
2:05
OncBrothers's profile picture

#GISeries: #Zolbetuximab was approved based off #GLOW & #SPOTLIGHT! We discussed the design, findings, sequencing and AEs/management w/ Kohei shitara Full Discussion: ⭐️ ⭐️ Also on the “Oncology Brothers” podcast #OncTwitter #MedTwitter #gism

Oncology Brothers

28,134 views • 1 year ago

#Cabozantinib is now approved in #NET based off #CABINET study! We discussed the design, findings, sequencing, and AEs w/ Aman Chauhan Full 🗣️: ⭐️ ⭐️ Also on the “Oncology Brothers” podcast #OncTwitter #MedTwitter #gism #GiOnc
1:05
OncBrothers's profile picture

#Cabozantinib is now approved in #NET based off #CABINET study! We discussed the design, findings, sequencing, and AEs w/ Aman Chauhan Full 🗣️: ⭐️ ⭐️ Also on the “Oncology Brothers” podcast #OncTwitter #MedTwitter #gism #GiOnc

Oncology Brothers

21,289 views • 1 year ago

HER2+ metastatic BTC Pt 3/3! Here we 🗣️ AEs, management, step down dosing for availabms Rx options (TDxD & Zanidatamab) w/ Rachna Shroff, MD, MS, FASCO Full 📢: 🌟 🌟 🌟Also on the “Oncology Brothers” podcast! #OncTwitter #MedTwitter #gism
0:51
OncBrothers's profile picture

HER2+ metastatic BTC Pt 3/3! Here we 🗣️ AEs, management, step down dosing for availabms Rx options (TDxD & Zanidatamab) w/ Rachna Shroff, MD, MS, FASCO Full 📢: 🌟 🌟 🌟Also on the “Oncology Brothers” podcast! #OncTwitter #MedTwitter #gism

Oncology Brothers

11,939 views • 1 year ago

#GISeries: #Tislelizumab is approved based off #RATIONALE305 & #RATIONALE306! We🗣️the design, findings, PDL1 testing + AEs w/ Anwaar Saeed Full 🗣️: ⭐️ ⭐️ ⭐️ Also on “Oncology Brothers” podcast #OncTwitter #MedTwitter #gism
1:59
OncBrothers's profile picture

#GISeries: #Tislelizumab is approved based off #RATIONALE305 & #RATIONALE306! We🗣️the design, findings, PDL1 testing + AEs w/ Anwaar Saeed Full 🗣️: ⭐️ ⭐️ ⭐️ Also on “Oncology Brothers” podcast #OncTwitter #MedTwitter #gism

Oncology Brothers

10,933 views • 1 year ago

No more content to load